CVS HEALTHSPIRE Trademark

Trademark Overview

On Friday, October 20, 2023, a trademark application was filed for CVS HEALTHSPIRE with the United States Patent and Trademark Office. The USPTO has given the CVS HEALTHSPIRE trademark a serial number of 98232673. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, October 31, 2024. This trademark is owned by CVS Pharmacy, Inc.. The CVS HEALTHSPIRE trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Custom manufacture of pharmaceutical products; Custom manufacture of generic prescription drugs
cvs healthspire

General Information

Serial Number98232673
Word MarkCVS HEALTHSPIRE
Filing DateFriday, October 20, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, October 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2024

Trademark Statements

Goods and ServicesCustom manufacture of pharmaceutical products; Custom manufacture of generic prescription drugs

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, October 25, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCVS Pharmacy, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWoonsocket, RI 02895
Party NameCVS Pharmacy, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoonsocket, RI 02895

Trademark Events

Event DateEvent Description
Tuesday, October 24, 2023NEW APPLICATION ENTERED
Wednesday, October 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 20, 2023NON-FINAL ACTION WRITTEN
Saturday, December 16, 2023ASSIGNED TO EXAMINER
Wednesday, December 20, 2023NON-FINAL ACTION E-MAILED
Wednesday, December 20, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 14, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 21, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 31, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 31, 2024SOU EXTENSION 1 GRANTED
Thursday, October 31, 2024SOU EXTENSION 1 FILED

Related Keywords

healthspire custom manufacture prescription drugs products pharmaceutical generic